Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by stockbuphoonon May 20, 2021 10:09am
39 Views
Post# 33237034

RE:they sold isle of man for 50 million they pocketed the mone

RE:they sold isle of man for 50 million they pocketed the moneEd, how did this money go to Thomvest/ Thomson? It was taken in by subliminal and spent like all the money that Liminal has received - $12M a month burn now peeled back to about $7-8M with huge bloated salaries based on a $2B market cap of hype in 2016. Thomvck doesn't care about paying these guys well as they are following his plan of failure. They should have 30-35 people in an R&D company partnering anything to commercializations as they have proven that they have NO skill in process and commercialization to get anything to sell. They knew potential of 4050 5 years ago with 5 positive efficacy results in 5 organs and they have done nothing but ramp up spending and decided after 4 years of doing nothing to do a MAD phase 1 study spending half a billion $$!$$!$$$!$$$$!!! So, what's Thomvck's plan? It's pretty obvious from most people's point of view

edrose wrote: the money retail investors never got a penny   they are doing the same thing   

THEY ARE RAPIDLY LIQUIDATING THE COMPANY 


<< Previous
Bullboard Posts
Next >>